• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗坏血酸对大鼠肺灌洗液中六价铬的还原作用。

Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid.

作者信息

Suzuki Y

机构信息

Department of Occupational Diseases, National Institute of Industrial Health, Kawasaki, Japan.

出版信息

Arch Toxicol. 1988;62(2-3):116-22. doi: 10.1007/BF00570129.

DOI:10.1007/BF00570129
PMID:3196146
Abstract

The reduction of hexavalent chromium [chromium(VI)] in lung lavage fluids, microsomal (S-9) fractions of lung and liver tissues, erythrocyte lysates and plasma prepared from adult rats was examined at pH 7.4 (37 degrees C). Specific reducing capacity, which was defined as the amount of chromium(VI) reduced per mg of protein in the test sample, was highest in the lavage fluids. The concomitant trivalent species [chromium(III)] was detected as complexes with some of the lavage components and probably as colloidal hydroxides. By gel filtration analysis and UV spectrometry, ascorbic acid (AsA) was identified as an important reducing factor in the lavage fluids. AsA levels in the lavage fluids were about 38 micrograms/g tissue, corresponding to 12% of total AsA in the intact lungs. The molar ratios of oxidized AsA and reduced chromium(VI) in the lavage samples were about 3:2.3 on an average. On the basis of this molar ratio, the AsA levels in the lavage fluids are equivalent to a reducing capacity of 8.4 micrograms chromium(VI)/g tissue. These results suggest that the lining layers (surfactant layers) of rat lungs provide an AsA-related capacity for protection of the cells against the toxic effects of chromates and probably other oxidants.

摘要

在pH 7.4(37℃)条件下,对成年大鼠肺灌洗液、肺和肝组织的微粒体(S-9)组分、红细胞裂解物及血浆中六价铬[铬(VI)]的还原情况进行了检测。比还原能力定义为测试样品中每毫克蛋白质还原铬(VI)的量,其在灌洗液中最高。伴随产生的三价铬[铬(III)]被检测为与某些灌洗成分形成的络合物,可能还有胶体氢氧化铬。通过凝胶过滤分析和紫外光谱法,已确定灌洗液中的抗坏血酸(AsA)是一种重要的还原因子。灌洗液中的AsA水平约为38微克/克组织,相当于完整肺组织中总AsA的12%。灌洗样品中氧化型AsA与还原型铬(VI)的摩尔比平均约为3:2.3。基于该摩尔比,灌洗液中的AsA水平相当于8.4微克铬(VI)/克组织的还原能力。这些结果表明,大鼠肺的内衬层(表面活性剂层)具有与AsA相关的能力,可保护细胞免受铬酸盐及可能其他氧化剂的毒性作用。

相似文献

1
Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid.抗坏血酸对大鼠肺灌洗液中六价铬的还原作用。
Arch Toxicol. 1988;62(2-3):116-22. doi: 10.1007/BF00570129.
2
Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung.抗坏血酸和谷胱甘肽对六价铬的还原作用,特别涉及大鼠肺脏
Arch Toxicol. 1990;64(3):169-76. doi: 10.1007/BF02010721.
3
Anion-exchange high-performance liquid chromatographic determination of ascorbic acid and hexavalent chromium in rat lung preparations after treatment with sodium chromate in vitro and in vivo.体外和体内用铬酸钠处理后大鼠肺制剂中抗坏血酸和六价铬的阴离子交换高效液相色谱测定
J Chromatogr. 1989 Apr 14;489(2):283-90. doi: 10.1016/s0378-4347(00)82906-0.
4
Chromium (VI) reducing capacity of ascorbic acid and of human plasma in vitro.
Arch Toxicol. 1992;66(1):45-50. doi: 10.1007/BF02307269.
5
Synergism of ascorbic acid and glutathione in the reduction of hexavalent chromium in vitro.体外抗坏血酸与谷胱甘肽在六价铬还原中的协同作用。
Ind Health. 1990;28(1):9-19. doi: 10.2486/indhealth.28.9.
6
Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity.
Carcinogenesis. 1997 Mar;18(3):531-7. doi: 10.1093/carcin/18.3.531.
7
Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.抗坏血酸盐是大鼠肺超滤液和细胞溶质中铬(VI)的主要还原剂,并在体外介导铬与DNA的结合。
Carcinogenesis. 1992 Aug;13(8):1319-24. doi: 10.1093/carcin/13.8.1319.
8
Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.DT-黄递酶作为一种降低六价铬并逆转其致突变性的细胞机制的重要作用。
Cancer Res. 1985 Jul;45(7):3188-96.
9
Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke.肺泡巨噬细胞对铬的代谢还原作用及其与香烟烟雾的关系。
J Clin Invest. 1986 Jun;77(6):1917-24. doi: 10.1172/JCI112520.
10
Therapeutic review: is ascorbic acid of value in chromium poisoning and chromium dermatitis?治疗综述:抗坏血酸对铬中毒和铬性皮炎有价值吗?
J Toxicol Clin Toxicol. 1999;37(2):195-200. doi: 10.1081/clt-100102419.

引用本文的文献

1
Short-Term PCB (Aroclor 1254) Toxicity on Few Phosphatases in Mice Brain.短期 PCB(Aroclor 1254)对小鼠大脑中少数几种磷酸酶的毒性。
Dose Response. 2013;11(1):1-8. doi: 10.2203/dose-response.10-037.Kundu. Epub 2011 Feb 10.
2
In vivo effects of chromium.铬的体内效应。
Environ Health Perspect. 1994 Sep;102 Suppl 3(Suppl 3):169-76. doi: 10.1289/ehp.94102s3169.
3
Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung.抗坏血酸和谷胱甘肽对六价铬的还原作用,特别涉及大鼠肺脏

本文引用的文献

1
The time-related subcellular distribution of chromium in the rat liver cell after intravenous administration of Na2 (51)CrO 4.静脉注射 Na2(51)CrO4 后铬在大鼠肝细胞中的时相关细胞内分布。
Biol Trace Elem Res. 1979 Mar;1(1):45-54. doi: 10.1007/BF02783842.
2
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
3
Properties, function and origin of the alveolar lining layer.肺泡衬里层的特性、功能及起源
Arch Toxicol. 1990;64(3):169-76. doi: 10.1007/BF02010721.
4
Acute toxic effect of sodium dichromate on metabolism.重铬酸钠对新陈代谢的急性毒性作用。
Arch Toxicol. 1990;64(8):644-9. doi: 10.1007/BF01974692.
5
Chromium (VI) reducing capacity of ascorbic acid and of human plasma in vitro.
Arch Toxicol. 1992;66(1):45-50. doi: 10.1007/BF02307269.
Nature. 1955 Jun 25;175(4469):1125-6. doi: 10.1038/1751125b0.
4
Pulmonary surface tension and the mucus lining of the lungs: some theoretical considerations.肺表面张力与肺的黏液内衬:一些理论思考。
J Appl Physiol. 1958 Mar;12(2):262-8. doi: 10.1152/jappl.1958.12.2.262.
5
Ascorbic acid analysis in biological fluids.生物体液中的抗坏血酸分析。
Anal Biochem. 1982 Jul 1;123(2):389-93. doi: 10.1016/0003-2697(82)90462-6.
6
The carcinogenicity of chromium.铬的致癌性。
Environ Health Perspect. 1981 Aug;40:121-30. doi: 10.1289/ehp.8140121.
7
Experimental bases for ascorbic acid therapy of poisoning by hexavalent chromium compounds.六价铬化合物中毒的抗坏血酸疗法的实验依据。
Int Arch Occup Environ Health. 1984;53(3):247-56. doi: 10.1007/BF00398817.
8
Quantitative studies of biological responses in hamsters exposed to tobacco smoke and effects of vitamin C supplement on smoke inhalation toxicity.对暴露于烟草烟雾中的仓鼠的生物反应进行定量研究以及维生素C补充剂对烟雾吸入毒性的影响。
Nihon Juigaku Zasshi. 1983 Oct;45(5):613-26. doi: 10.1292/jvms1939.45.613.
9
Distribution of chromium in rats exposed to hexavalent chromium and trivalent chromium aerosols.
Ind Health. 1984;22(4):261-77. doi: 10.2486/indhealth.22.261.
10
The reduction of chromium (VI) to chromium (III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen chromate.谷胱甘肽将六价铬还原为三价铬:致癌物铬酸盐代谢中的一种细胞内氧化还原途径。
Toxicology. 1984 Dec;33(3-4):341-8. doi: 10.1016/0300-483x(84)90050-7.